HK1092151A1 - Polymorphous forms of rifaximin as antibiotics - Google Patents
Polymorphous forms of rifaximin as antibioticsInfo
- Publication number
- HK1092151A1 HK1092151A1 HK06113864.0A HK06113864A HK1092151A1 HK 1092151 A1 HK1092151 A1 HK 1092151A1 HK 06113864 A HK06113864 A HK 06113864A HK 1092151 A1 HK1092151 A1 HK 1092151A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- rifaximin
- antibiotics
- polymorphous forms
- polymorphous
- forms
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 title 1
- 229960003040 rifaximin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B6/00—Heating by electric, magnetic or electromagnetic fields
- H05B6/02—Induction heating
- H05B6/10—Induction heating apparatus, other than furnaces, for specific applications
- H05B6/12—Cooking devices
- H05B6/1209—Cooking devices induction cooking plates or the like and devices to be used in combination with them
- H05B6/1236—Cooking devices induction cooking plates or the like and devices to be used in combination with them adapted to induce current in a coil to supply power to a device and electrical heating devices powered in this way
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B6/00—Heating by electric, magnetic or electromagnetic fields
- H05B6/02—Induction heating
- H05B6/10—Induction heating apparatus, other than furnaces, for specific applications
- H05B6/12—Cooking devices
- H05B6/1209—Cooking devices induction cooking plates or the like and devices to be used in combination with them
- H05B6/1245—Cooking devices induction cooking plates or the like and devices to be used in combination with them with special coil arrangements
- H05B6/1263—Cooking devices induction cooking plates or the like and devices to be used in combination with them with special coil arrangements using coil cooling arrangements
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Electromagnetism (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HK06113864.0A HK1092151A1 (en) | 2003-11-07 | 2005-08-04 | Polymorphous forms of rifaximin as antibiotics |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002144A ITMI20032144A1 (it) | 2003-11-07 | 2003-11-07 | Forme polimorfe di rifaximina, processi per ottenerle e |
HK05106702A HK1073657A1 (en) | 2003-11-07 | 2005-08-04 | Polymorphous form of rifaximin as antibiotic |
HK06113864.0A HK1092151A1 (en) | 2003-11-07 | 2005-08-04 | Polymorphous forms of rifaximin as antibiotics |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1092151A1 true HK1092151A1 (en) | 2007-02-02 |
Family
ID=33187382
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06113863.1A HK1092150A1 (en) | 2003-11-07 | 2005-08-04 | Polymorphous forms of rifaximin as antibiotics |
HK05106702A HK1073657A1 (en) | 2003-11-07 | 2005-08-04 | Polymorphous form of rifaximin as antibiotic |
HK06113864.0A HK1092151A1 (en) | 2003-11-07 | 2005-08-04 | Polymorphous forms of rifaximin as antibiotics |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06113863.1A HK1092150A1 (en) | 2003-11-07 | 2005-08-04 | Polymorphous forms of rifaximin as antibiotics |
HK05106702A HK1073657A1 (en) | 2003-11-07 | 2005-08-04 | Polymorphous form of rifaximin as antibiotic |
Country Status (38)
Country | Link |
---|---|
US (5) | US7045620B2 (xx) |
EP (6) | EP1557421B1 (xx) |
JP (5) | JP2005139161A (xx) |
KR (4) | KR20050043589A (xx) |
CN (4) | CN1613858A (xx) |
AR (3) | AR043547A1 (xx) |
AT (3) | ATE421966T1 (xx) |
AU (2) | AU2004200964A1 (xx) |
BR (2) | BRPI0402382A (xx) |
CA (2) | CA2460384A1 (xx) |
CL (1) | CL2004000498A1 (xx) |
CO (1) | CO5560083A1 (xx) |
CY (3) | CY1108017T1 (xx) |
DE (4) | DE602004006367C5 (xx) |
DK (3) | DK1557421T3 (xx) |
ES (3) | ES2320161T3 (xx) |
HK (3) | HK1092150A1 (xx) |
HR (2) | HRP20040265A2 (xx) |
IL (2) | IL160798A0 (xx) |
IT (1) | ITMI20032144A1 (xx) |
JO (1) | JO2470B1 (xx) |
MA (1) | MA27069A1 (xx) |
MD (1) | MD3653G8 (xx) |
ME (1) | ME00424B (xx) |
MX (2) | MXPA04002353A (xx) |
NO (1) | NO334950B1 (xx) |
NZ (1) | NZ531622A (xx) |
PL (3) | PL1557421T3 (xx) |
PT (3) | PT1557421E (xx) |
RS (4) | RS54571B1 (xx) |
RU (1) | RU2270200C2 (xx) |
SI (3) | SI1557421T1 (xx) |
TN (2) | TNSN04044A1 (xx) |
TW (1) | TWI285107B (xx) |
UA (1) | UA86384C2 (xx) |
WO (1) | WO2005044823A2 (xx) |
YU (1) | YU24804A (xx) |
ZA (1) | ZA200401948B (xx) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US7906542B2 (en) * | 2004-11-04 | 2011-03-15 | Alfa Wassermann, S.P.A. | Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin |
US20080262024A1 (en) * | 2003-11-07 | 2008-10-23 | Giuseppe Claudio Viscomi | Rifaximin compositions and method of use |
ITMI20032144A1 (it) * | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
US7902206B2 (en) * | 2003-11-07 | 2011-03-08 | Alfa Wassermann, S.P.A. | Polymorphic forms α, β and γ of rifaximin |
US7923553B2 (en) * | 2003-11-07 | 2011-04-12 | Alfa Wassermann, S.P.A. | Processes for the production of polymorphic forms of rifaximin |
DK1698630T3 (da) * | 2005-03-03 | 2014-12-08 | Alfa Wassermann Spa | Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater |
ITBO20050123A1 (it) * | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
CA2659874C (en) | 2006-08-02 | 2016-10-11 | Salix Pharmaceuticals, Inc. | Methods for the treatment of radiation proctosigmoiditis |
ITMI20061692A1 (it) * | 2006-09-05 | 2008-03-06 | Alfa Wassermann Spa | Uso di polioli per ottenere forme polimorfe stabili di rifaximina |
EP2069363B1 (en) * | 2006-09-22 | 2013-03-20 | Cipla Ltd. | Rifaximin in an amorphous form |
US20080159987A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Restless Legs Syndrome |
US20080161337A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Chronic Prostatitis |
ITMI20071241A1 (it) * | 2007-06-20 | 2008-12-21 | Solmag S P A | Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta |
AU2016203925B2 (en) * | 2007-07-06 | 2016-10-20 | Lupin Limited | Pharmaceutical compositions of rifaximin |
AU2008273699A1 (en) * | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions of rifaximin |
DK2011486T3 (da) * | 2007-07-06 | 2012-09-03 | Lupin Ltd | Farmaceutiske sammensætninger af rifaximin |
US7709634B2 (en) * | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
CN102015725B (zh) | 2008-02-25 | 2014-10-22 | 萨利克斯药品有限公司 | 利福昔明的多种形式及其用途 |
US8486956B2 (en) * | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
PL2252148T3 (pl) * | 2008-02-26 | 2019-09-30 | Salix Pharmaceuticals, Ltd. | Sposoby leczenia zespołu jelita drażliwego |
US11779571B2 (en) | 2008-02-26 | 2023-10-10 | Salix Pharmaceuticals, Inc. | Methods for treating irritable bowel syndrome (IBS) |
DK2294012T3 (da) | 2008-05-07 | 2014-10-06 | Salix Pharmaceuticals Ltd | Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdom |
ES2496190T3 (es) | 2008-09-26 | 2014-09-18 | Aska Pharmaceutical Co., Ltd. | Agente profiláctico y/o terapéutico para trastornos gastrointestinales funcionales |
US7928115B2 (en) | 2008-10-02 | 2011-04-19 | Salix Pharmaceuticals, Ltd. | Methods of treating travelers diarrhea and hepatic encephalopathy |
SI3628319T1 (sl) | 2008-10-02 | 2024-04-30 | Salix Pharmaceuticals, Ltd. | Zdravljenje jetrne encefalopatije z rifaksiminom |
US20100317681A1 (en) * | 2009-06-15 | 2010-12-16 | Salix Pharmaceuticals, Ltd. | Modulation of systemic exposure to rifaximin |
US20110035232A1 (en) | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
JP5756020B2 (ja) | 2008-12-10 | 2015-07-29 | シプラ・リミテッド | リファキシミン複合体 |
IT1397617B1 (it) * | 2009-04-20 | 2013-01-18 | Alfa Wassermann Spa | Nuovi derivati della rifamicina |
NZ596851A (en) * | 2009-06-02 | 2013-10-25 | Salix Pharmaceuticals Ltd | Methods of treating hepatic encephalopathy |
KR20120062897A (ko) | 2009-09-13 | 2012-06-14 | 샐릭스 파마슈티컬스 리미티드 | 과민성 장 증후군(ibs)의 치료방법 |
KR20200100215A (ko) * | 2009-10-27 | 2020-08-25 | 루핀 리미티드 | 리팍시민의 고형 분산물 |
WO2011061748A1 (en) * | 2009-11-19 | 2011-05-26 | Strides Arcolab Limited | Rifaximin premix |
BR112012012316A2 (pt) | 2009-11-23 | 2016-04-26 | Cipla Ltd | composição farmacêutica para administração retal tópica na forma de espuma, uso de uma composição farmacêutica, método para tratamento, prevenção ou alívio de um dustúrbio no reto, cólon, íleo terminal ou ânus, processo para fabricação de uma composição farmacêutica contendo rifaximina, uso de um silicone e dispensador para composição farmacêutica |
WO2011080691A1 (en) | 2009-12-28 | 2011-07-07 | Silvio Massimo Lavagna | Method for the production of amorphous rifaximin |
AU2011218129A1 (en) | 2010-02-18 | 2012-08-23 | Board Of Regents Of The University Of Texas System | Methods for treating infection |
IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
CA2800668A1 (en) * | 2010-06-03 | 2011-12-08 | Salix Pharmaceuticals, Ltd. | Forms of rifaximin and uses thereof |
WO2011156897A2 (en) * | 2010-06-16 | 2011-12-22 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
CN103228662B (zh) | 2010-07-12 | 2016-08-10 | 萨利克斯药品有限公司 | 利福昔明的制剂及其用途 |
US8759513B2 (en) | 2010-09-13 | 2014-06-24 | Sequent Scientific Limited | Polymorphic form of rifaximin and process for its preparation |
IT1403847B1 (it) | 2010-09-22 | 2013-11-08 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina e loro uso. |
WO2012060675A1 (es) * | 2010-11-05 | 2012-05-10 | Interquim, S.A. De C.V. | Proceso para la preparación de rifaximina amorfa |
WO2012076832A1 (en) * | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
US8735419B2 (en) * | 2011-02-11 | 2014-05-27 | Salix Pharmaceuticals, Ltd. | Forms of rifaximin and uses thereof |
CA2834829A1 (en) | 2011-05-02 | 2012-11-08 | Ranbaxy Laboratories Limited | Rifaximin dimethylformamide solvate |
ITMI20110890A1 (it) * | 2011-05-19 | 2012-11-20 | A M S A Anonima Materie Sint & Affini S P A | Polimorfo di rifaximina e processo per la sua preparazione |
WO2012155981A1 (en) | 2011-05-19 | 2012-11-22 | Friulchem Spa | New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby |
ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
AU2012332211B2 (en) * | 2011-11-02 | 2016-11-24 | Salix Pharmaceuticals, Ltd. | Methods for treating irritable bowel syndrome (IBS) and infections |
JP2013184902A (ja) * | 2012-03-06 | 2013-09-19 | Aska Pharmaceutical Co Ltd | リファキシミン含有結晶 |
US9359374B2 (en) | 2012-06-13 | 2016-06-07 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
ITBO20120368A1 (it) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso. |
US9849090B2 (en) | 2012-12-12 | 2017-12-26 | Sun Pharmaceutical Industries Limited | Pharmaceutical compositions of rifaximin |
US20160038468A1 (en) | 2013-03-15 | 2016-02-11 | Alfa Wassermann S.P.A. | Rifaximin for use in the treating of vaginal infections |
EP2971062A2 (en) | 2013-03-15 | 2016-01-20 | ALFA WASSERMANN S.p.A. | Method for diagnosing vaginal infections |
JP6433980B2 (ja) | 2013-04-12 | 2018-12-05 | アルファシグマ ソシエタ ペル アチオニ | Nsaid投与並びに関連する組成物、方法及びシステム |
US9018225B1 (en) | 2013-07-26 | 2015-04-28 | Novel Laboratories | Rifaximin crystalline forms and methods of preparation thereof |
ES2621557T3 (es) | 2014-03-31 | 2017-07-04 | Euticals S.P.A. | Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas |
CA2946101A1 (en) | 2014-04-19 | 2015-10-22 | Granules India Limited | An improved process for the preparation of rifamycin derivatives |
CA2947962C (en) | 2014-05-04 | 2024-01-16 | Salix Pharmaceuticals, Inc. | Ibs microbiota and uses thereof |
ES2742106T3 (es) | 2014-05-12 | 2020-02-13 | Alfasigma Spa | Nueva forma de cristal solvatado de rifaximina, producción, composiciones y usos de la misma |
WO2016003536A1 (en) * | 2014-06-30 | 2016-01-07 | Salix Pharmaceuticals, Inc. | Methods for retreating irritable bowel syndrome (ibs) |
CN104083324B (zh) * | 2014-07-10 | 2017-05-10 | 青岛动保国家工程技术研究中心有限公司 | 一种利福昔明的兽用悬乳剂及其制备方法和应用 |
EP2982764A1 (en) | 2014-08-05 | 2016-02-10 | ALFA WASSERMANN S.p.A. | Identification of vaginal bacteria |
CN104274391B (zh) * | 2014-10-08 | 2017-02-01 | 哈尔滨坤盟医药科技有限公司 | 一种含利福昔明的药物制剂 |
WO2017021975A1 (en) * | 2015-08-06 | 2017-02-09 | Msn Laboratories Private Limited | Process for the preparation of crystalline forms of rifaximin |
PL3434265T3 (pl) | 2016-03-24 | 2021-12-13 | Sandoz Ag | Kompozycja farmaceutyczna zawierająca rifaksyminę alfa i delta |
US10842782B2 (en) | 2016-03-24 | 2020-11-24 | Sandoz Ag | Storage stable composition comprising rifaximin alpha |
US9988398B2 (en) * | 2016-06-07 | 2018-06-05 | Cadila Healthcare Limited | Crystalline form of rifaximin and process for its preparation |
WO2018064472A1 (en) | 2016-09-30 | 2018-04-05 | Salix Pharmaceuticals, Ltd. | Solid dispersion forms of rifaximin |
CN106632396B (zh) * | 2017-01-06 | 2019-01-11 | 成都樵枫科技发展有限公司 | γ晶型利福昔明的制备方法和用途 |
CA3013161C (en) | 2017-04-26 | 2020-03-24 | Sandoz Ag | Oral dosage form comprising rifaximin in form beta |
PL3645539T3 (pl) | 2017-06-26 | 2021-10-25 | Biofer S.P.A. | Pochodne pirydoimidazoryfamycyny jako środek przeciwbakteryjny |
WO2020245214A1 (en) | 2019-06-03 | 2020-12-10 | Bausch Health Ireland Limited | Use of methylnaltrexone and rifaximin for treatment of increased gut permeability or associated disorders |
US20220378758A1 (en) | 2019-09-24 | 2022-12-01 | Bausch Health Ireland Limited | Rifaximin liquid formulations |
WO2021191312A1 (en) | 2020-03-24 | 2021-09-30 | Bausch Health Ireland Limited | Methods of treating covid-19 with rifaximin |
WO2021229480A1 (en) * | 2020-05-15 | 2021-11-18 | Atra Pharmaceuticals Limited | Polymorph of rifaximin, process for the preparation thereof and pharmaceutical composition containing rifaximin |
CA3184054A1 (en) | 2020-06-26 | 2021-12-30 | Jacob Cole | Targeted release rifaximin compositions |
WO2022090490A1 (en) | 2020-10-29 | 2022-05-05 | Bausch Health Ireland Limited | Rifaximin liquid formulations for use in the treatment of sickle cell disease |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241785A (en) * | 1978-07-24 | 1980-12-30 | Peerless Of America, Inc. | Heat exchangers and method of making same |
IT1154655B (it) * | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
IT1199374B (it) * | 1984-05-15 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
CA1215976A (en) | 1984-05-15 | 1986-12-30 | Vincenzo Cannata | New process for the synthesis of imidazo rifamycins |
IT1199413B (it) | 1984-09-26 | 1988-12-30 | Alfa Farmaceutici Spa | Processo per la preparazione di pirido-imidazo-rifamicine |
GB8816620D0 (en) * | 1988-07-13 | 1988-08-17 | Lepetit Spa | Rifapentine hydrohalides |
ATE125541T1 (de) * | 1990-06-29 | 1995-08-15 | Lepetit Spa | Reine kristalline form von rifapentin. |
CZ20022332A3 (cs) * | 2000-01-07 | 2003-01-15 | Transform Pharmaceuticals, Inc. | Sestava vzorků |
UA75365C2 (en) * | 2000-08-16 | 2006-04-17 | Bristol Myers Squibb Co | Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon |
CN100338028C (zh) * | 2000-10-31 | 2007-09-19 | 山道士有限公司 | 盐酸文拉法辛的晶形 |
IL156055A0 (en) * | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
US20050262269A1 (en) | 2004-05-20 | 2005-11-24 | Pike Jimmy D | System and method for information handling system PCI express advanced switching |
DK1698630T3 (da) | 2005-03-03 | 2014-12-08 | Alfa Wassermann Spa | Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater |
EP2069363B1 (en) * | 2006-09-22 | 2013-03-20 | Cipla Ltd. | Rifaximin in an amorphous form |
WO2008115572A1 (en) | 2007-03-21 | 2008-09-25 | Theraquest Biosciences, Inc. | Methods and compositions of nsaids |
ITMI20071241A1 (it) | 2007-06-20 | 2008-12-21 | Solmag S P A | Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta |
AU2008273699A1 (en) | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions of rifaximin |
DK2011486T3 (da) | 2007-07-06 | 2012-09-03 | Lupin Ltd | Farmaceutiske sammensætninger af rifaximin |
US7709634B2 (en) * | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
WO2009047801A1 (en) | 2007-10-10 | 2009-04-16 | Lupin Limited | Therapeutic combinations and compositions for the treatment of gastrointestinal disorders |
CN102015725B (zh) | 2008-02-25 | 2014-10-22 | 萨利克斯药品有限公司 | 利福昔明的多种形式及其用途 |
-
2003
- 2003-11-07 IT IT002144A patent/ITMI20032144A1/it unknown
- 2003-12-05 US US10/728,090 patent/US7045620B2/en not_active Expired - Lifetime
-
2004
- 2004-03-09 ES ES06004220T patent/ES2320161T3/es not_active Expired - Lifetime
- 2004-03-09 DK DK04005541T patent/DK1557421T3/da active
- 2004-03-09 ES ES04005541T patent/ES2244364T3/es not_active Expired - Lifetime
- 2004-03-09 AT AT06004220T patent/ATE421966T1/de active
- 2004-03-09 DE DE602004006367.3T patent/DE602004006367C5/de not_active Expired - Lifetime
- 2004-03-09 DE DE602004019298T patent/DE602004019298D1/de not_active Expired - Lifetime
- 2004-03-09 PL PL04005541T patent/PL1557421T3/pl unknown
- 2004-03-09 DE DE04005541T patent/DE04005541T1/de active Pending
- 2004-03-09 EP EP04005541A patent/EP1557421B1/en not_active Expired - Lifetime
- 2004-03-09 EP EP06004219A patent/EP1676847B1/en not_active Expired - Lifetime
- 2004-03-09 PT PT04005541T patent/PT1557421E/pt unknown
- 2004-03-09 PL PL06004219T patent/PL1676847T3/pl unknown
- 2004-03-09 PT PT06004220T patent/PT1676848E/pt unknown
- 2004-03-09 NZ NZ531622A patent/NZ531622A/en not_active IP Right Cessation
- 2004-03-09 IL IL16079804A patent/IL160798A0/xx unknown
- 2004-03-09 PT PT06004219T patent/PT1676847E/pt unknown
- 2004-03-09 AT AT06004219T patent/ATE421965T1/de active
- 2004-03-09 DK DK06004220T patent/DK1676848T3/da active
- 2004-03-09 DK DK06004219T patent/DK1676847T3/da active
- 2004-03-09 DE DE602004019296T patent/DE602004019296D1/de not_active Expired - Lifetime
- 2004-03-09 SI SI200430297T patent/SI1557421T1/sl unknown
- 2004-03-09 EP EP06004220A patent/EP1676848B1/en not_active Expired - Lifetime
- 2004-03-09 SI SI200431070T patent/SI1676848T1/sl unknown
- 2004-03-09 SI SI200431074T patent/SI1676847T1/sl unknown
- 2004-03-09 CA CA002460384A patent/CA2460384A1/en not_active Abandoned
- 2004-03-09 AT AT04005541T patent/ATE361927T1/de active
- 2004-03-09 ES ES06004219T patent/ES2320160T4/es not_active Expired - Lifetime
- 2004-03-09 PL PL06004220T patent/PL1676848T3/pl unknown
- 2004-03-10 AU AU2004200964A patent/AU2004200964A1/en not_active Abandoned
- 2004-03-10 ZA ZA200401948A patent/ZA200401948B/xx unknown
- 2004-03-11 CO CO04022467A patent/CO5560083A1/es not_active Application Discontinuation
- 2004-03-11 MX MXPA04002353A patent/MXPA04002353A/es unknown
- 2004-03-11 CL CL200400498A patent/CL2004000498A1/es unknown
- 2004-03-11 AR ARP040100781A patent/AR043547A1/es not_active Application Discontinuation
- 2004-03-16 TW TW093106943A patent/TWI285107B/zh not_active IP Right Cessation
- 2004-03-16 CN CNA2004100477623A patent/CN1613858A/zh active Pending
- 2004-03-17 KR KR1020040017892A patent/KR20050043589A/ko not_active Application Discontinuation
- 2004-03-17 JP JP2004076458A patent/JP2005139161A/ja active Pending
- 2004-03-18 HR HRP20040265 patent/HRP20040265A2/hr not_active Application Discontinuation
- 2004-03-18 JO JO200433A patent/JO2470B1/en active
- 2004-03-18 RU RU2004108953/04A patent/RU2270200C2/ru active
- 2004-03-19 YU YU24804A patent/YU24804A/sh unknown
- 2004-03-19 BR BR0402382-0A patent/BRPI0402382A/pt not_active IP Right Cessation
- 2004-03-19 TN TNP2004000044A patent/TNSN04044A1/en unknown
- 2004-03-24 MA MA27590A patent/MA27069A1/fr unknown
- 2004-04-11 UA UAA200602354A patent/UA86384C2/uk unknown
- 2004-11-04 BR BRPI0407149A patent/BRPI0407149A8/pt not_active Application Discontinuation
- 2004-11-04 RS RS20150292A patent/RS54571B1/en unknown
- 2004-11-04 EP EP04797615A patent/EP1682556A2/en not_active Withdrawn
- 2004-11-04 KR KR1020057013910A patent/KR100855084B1/ko active IP Right Review Request
- 2004-11-04 JP JP2006537252A patent/JP5199576B2/ja active Active
- 2004-11-04 CA CA2538546A patent/CA2538546C/en active Active
- 2004-11-04 EP EP10004590A patent/EP2208730A1/en not_active Withdrawn
- 2004-11-04 CN CN2008100869327A patent/CN101260115B/zh active Active
- 2004-11-04 AU AU2004287601A patent/AU2004287601B8/en active Active
- 2004-11-04 MD MDA20060080A patent/MD3653G8/ro active IP Right Grant
- 2004-11-04 RS RS20150291A patent/RS54569B1/en unknown
- 2004-11-04 ME MEP-2008-633A patent/ME00424B/me unknown
- 2004-11-04 EP EP10004589A patent/EP2210893A1/en not_active Withdrawn
- 2004-11-04 RS YUP-2006/0168A patent/RS20060168A/sr unknown
- 2004-11-04 CN CN2004800030228A patent/CN1886408B/zh active Active
- 2004-11-04 WO PCT/EP2004/012490 patent/WO2005044823A2/en active Application Filing
- 2004-11-04 KR KR1020077026409A patent/KR100883216B1/ko active IP Right Grant
- 2004-11-04 CN CN2008100869308A patent/CN101260114B/zh active Active
- 2004-11-04 RS RS20060168A patent/RS54568B1/en unknown
- 2004-11-04 KR KR1020077026410A patent/KR100867751B1/ko active IP Right Grant
- 2004-11-04 MX MXPA06002644A patent/MXPA06002644A/es active IP Right Grant
-
2005
- 2005-05-24 US US11/135,651 patent/US20050272754A1/en not_active Abandoned
- 2005-08-04 HK HK06113863.1A patent/HK1092150A1/xx not_active IP Right Cessation
- 2005-08-04 HK HK05106702A patent/HK1073657A1/xx not_active IP Right Cessation
- 2005-08-04 HK HK06113864.0A patent/HK1092151A1/xx not_active IP Right Cessation
-
2006
- 2006-03-01 TN TNP2006000069A patent/TNSN06069A1/en unknown
- 2006-03-08 NO NO20061110A patent/NO334950B1/no unknown
- 2006-03-08 HR HRP20060093AA patent/HRP20060093B1/hr active IP Right Grant
- 2006-03-12 IL IL174271A patent/IL174271A/en active IP Right Grant
-
2007
- 2007-07-02 CY CY20071100875T patent/CY1108017T1/el unknown
- 2007-10-17 US US11/873,841 patent/US7915275B2/en active Active
-
2009
- 2009-03-23 CY CY20091100319T patent/CY1108909T1/el unknown
- 2009-04-09 CY CY20091100414T patent/CY1108964T1/el unknown
-
2010
- 2010-11-19 JP JP2010259453A patent/JP5635376B2/ja active Active
- 2010-11-19 JP JP2010259452A patent/JP2011057698A/ja not_active Withdrawn
-
2011
- 2011-03-04 US US13/041,346 patent/US8173801B2/en active Active
- 2011-03-04 US US13/041,348 patent/US8404704B2/en active Active
- 2011-06-23 AR ARP110102194A patent/AR081992A2/es not_active Application Discontinuation
- 2011-06-23 AR ARP110102193A patent/AR081991A2/es not_active Application Discontinuation
-
2014
- 2014-07-04 JP JP2014138697A patent/JP2014177500A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1092150A1 (en) | Polymorphous forms of rifaximin as antibiotics | |
HK1093483A1 (en) | Polymorphic form of n- | |
IL169905A0 (en) | Novel 2-pyridinecarboxamide derivatives | |
GB0304424D0 (en) | Novel compounds | |
EP1596860A4 (en) | NEW CONNECTIONS | |
EP1648885A4 (en) | NEW CONNECTIONS | |
EP1487414A4 (en) | ANTIBIOTIC COMPOSITION | |
EP1620101A4 (en) | POLYMORPHS OF CABERGOLIN | |
ZA200507475B (en) | Derivatives of azithromycin | |
GB0312368D0 (en) | Novel ureido- and amido-pyrazolone derivatives | |
GB0315629D0 (en) | New uses for antibiotic | |
EP1793812A4 (en) | ANTIBIOTIC COMPOUND | |
GB0302546D0 (en) | Novel compounds | |
EP1756034A4 (en) | ANTIBIOTIC COMPOUND | |
EP1635834A4 (en) | NEW COMPOUNDS | |
GB0302008D0 (en) | Antibiotic derivatives | |
PL378080A1 (pl) | Sposób wytwarzania K-252A | |
GB0303767D0 (en) | Gentamycin antibiotics | |
GB0303874D0 (en) | Novel antibacterial compounds | |
TW568246U (en) | Gasifying kiln | |
PL114147U1 (en) | Interior decoration element | |
GB0301480D0 (en) | Novel compounds | |
GB0301589D0 (en) | Novel compounds | |
GB0300484D0 (en) | Novel compounds | |
GB0300483D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20240308 |